文献
J-GLOBAL ID:202202290056875602
整理番号:22A0705788
アクチビン/FLRG経路は入院患者におけるCOVID-19転帰不良と関連する【JST・京大機械翻訳】
The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients
著者 (17件):
McAleavy Megan
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Zhang Qian
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Ehmann Peter J.
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Xu Jianing
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Wipperman Matthew F.
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Ajithdoss Dharani
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Pan Li
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Wakai Matthew
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Simonson Raphael
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Gadi Abhilash
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Oyejide Adelekan
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Hamon Sara C.
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Boyapati Anita
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Morton Lori G.
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Shavlakadze Tea
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Kyratsous Christos A.
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
,
Glass David J.
(Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA)
資料名:
Molecular and Cellular Biology
(Molecular and Cellular Biology)
巻:
42
号:
1
ページ:
Null
発行年:
2022年
JST資料番号:
E0266B
ISSN:
0270-7306
CODEN:
MCEBD4
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)